Prospective study of efficiency of fibrosis score in computed tomography as predictor after treatment with Nintedanib for idiopathic pulmonary fibrosis
Not Applicable
Recruiting
- Conditions
- idiopathic pulmonary fibrosis
- Registration Number
- JPRN-UMIN000020722
- Lead Sponsor
- Kanagawa Cardiovascular and Respiratory Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) AST/ALT/T-bil are is more than reference value 2.5 times 2)Patient who was determined as ineligible by the investigator or the subinvestigator. 3) The patients who has already received corticosteroid (over 10mg/day), immunosupressant, N-acetylcysteine , pirfenidone, and other treatment for IPF 4) Active infection and other severe complication 5) Malignant tumor 6) case was determined as ineligible by attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method